Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maria E. Tamayo"'
Autor:
J.F. Marier, Janet B Bautista, Myra L. Patchen, Michele Gargano, Richard Walsh, Paulo S Tioleco, Myra L Flores, Gerardo H Cornelio, Maria E Tamayo, Martin Beliveau, Michael R Kurman
Publikováno v:
Colorectal Cancer. 5:95-108
Aim: Investigate the safety, pharmacokinetics (PK) and efficacy of BTH1677/cetuximab, with and without irinotecan, in patients with metastatic colorectal cancer (mCRC). Patients & methods: Patients with recurrent or progressive mCRC were assigned to
Autor:
María I. Lalinde, Jorge Acosta, Juan Manuel Lozano, José Fernando Vera, Carlos Bernal Parra, Germán Briceño, Javier Contreras, Ivan D. Florez, Luz Helena Lugo, Maria E. Tamayo, Javier M. Sierra, Fernando Sarmiento, Claudia Granados
Publikováno v:
Pediatría. 48(2):29-46
ResumenComo parte del proyecto nacional de Guías de Práctica Clínica (GPC) del Ministerio de Salud, y bajo la coordinación administrativa y financiera del Departamento Administrativo de Ciencia, Tecnología e Innovación (Colciencias), el Grupo d
Autor:
Dagfinn Aune, Lehana Thabane, Areti Angeliki Veroniki, Ivan D. Florez, Maria E. Tamayo, Lawrence Mbuagbaw, Souvik Mitra
Publikováno v:
BMJ Open
Introduction Management of patent ductus arteriosus (PDA) in preterm infants is one of the most controversial topics in neonatal medicine. The availability of different pharmacotherapeutic options often poses a practical challenge to the practising n
Autor:
Behnam Sadeghirad, Ivan D. Florez, Areti Angeliki Veroniki, Lawrence Mbuagbaw, Souvik Mitra, Maria E. Tamayo, Adriana M. Zea, Lehana Thabane, Yuan Zhang, Thuva Vanniyasingam
Publikováno v:
JAMA. 319:1221
Importance Despite increasing emphasis on conservative management of patent ductus arteriosus (PDA) in preterm infants, different pharmacotherapeutic interventions are used to treat those developing a hemodynamically significant PDA. Objectives To es
Autor:
Luis Alfonso Perez, Maria M. Archila, Martín Rondón, Gloria Ruiz, Oscar Ovalle, María Ximena Rojas, Maria E. Tamayo, Jorge E. Garcia-Harker, Juan Lozano, Mario A. Rojas, Jaime Bastidas, Catherine Rojas, Mauricio Arevalo, Viviana Rodríguez, Adriana Ballesteros
Publikováno v:
Pediatrics. 130(5)
BACKGROUND AND OBJECTIVE: It has been suggested that probiotics may decrease infant mortality and nosocomial infections because of their ability to suppress colonization and translocation of bacterial pathogens in the gastrointestinal tract. We desig
Publikováno v:
Pediatría. (1):23-35
IntroductionBronchopulmonary dysplasia has been associated with multiple risk factors: low birth weight, low gestational age, respiratory distress syndrome, oxygen toxicity, infection, excessive fluids (especially during the first week of life) and p